Carole Leroy

496 total citations
18 papers, 342 citations indexed

About

Carole Leroy is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Carole Leroy has authored 18 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Carole Leroy's work include Multiple Sclerosis Research Studies (6 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Carole Leroy is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Carole Leroy collaborates with scholars based in France, Belgium and Australia. Carole Leroy's co-authors include Virginie Gonzalez, Violaine David, Nicholas A. Malmquist, Audrey Combe, Robert Ménard, Isabelle Tardieux, Samantha Blazquez, Pierre Fenaux, Guido Kroemer and Élodie Lainey and has published in prestigious journals such as Blood, Oncogene and The Journal of Infectious Diseases.

In The Last Decade

Carole Leroy

16 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Leroy France 8 110 86 73 68 63 18 342
Norbert Blödorn‐Schlicht Germany 12 66 0.6× 28 0.3× 35 0.5× 99 1.5× 99 1.6× 20 335
Hanoch Goldshmidt Israel 10 146 1.3× 44 0.5× 18 0.2× 111 1.6× 26 0.4× 19 407
Paula Embury United States 10 106 1.0× 24 0.3× 24 0.3× 107 1.6× 50 0.8× 20 369
J.M.R. Saint-Remy Belgium 10 38 0.3× 28 0.3× 23 0.3× 193 2.8× 23 0.4× 15 440
Anne Müller Switzerland 10 76 0.7× 42 0.5× 18 0.2× 190 2.8× 158 2.5× 24 449
Alessandra G. Commodaro Brazil 15 205 1.9× 19 0.2× 227 3.1× 274 4.0× 41 0.7× 32 690
Jenny L. Hardison United States 9 53 0.5× 9 0.1× 38 0.5× 205 3.0× 60 1.0× 9 426
Renee C. Duncan Australia 11 88 0.8× 99 1.2× 11 0.2× 336 4.9× 30 0.5× 17 514
Troels R. Kjær Denmark 13 98 0.9× 126 1.5× 22 0.3× 435 6.4× 18 0.3× 17 580
Nadine Cogné France 11 167 1.5× 25 0.3× 353 4.8× 238 3.5× 43 0.7× 13 748

Countries citing papers authored by Carole Leroy

Since Specialization
Citations

This map shows the geographic impact of Carole Leroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Leroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Leroy more than expected).

Fields of papers citing papers by Carole Leroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Leroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Leroy. The network helps show where Carole Leroy may publish in the future.

Co-authorship network of co-authors of Carole Leroy

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Leroy. A scholar is included among the top collaborators of Carole Leroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Leroy. Carole Leroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ruiz, Anne, Pascale Giraudon, Lakhdar Benyahya, et al.. (2025). MOG antibody non-P42 epitope is associated with a higher risk of relapse in paediatric MOGAD. Journal of Neurology Neurosurgery & Psychiatry. 96(8). 753–756. 2 indexed citations
2.
Chrétien, Pascale, Laetitia Giorgi, Carole Leroy, et al.. (2024). The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis. Multiple Sclerosis Journal. 30(11-12). 1436–1444. 4 indexed citations
3.
Galati, Giacomo, Julie Pique, Philippe Horellou, et al.. (2024). Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases. European Journal of Paediatric Neurology. 51. 79–83.
4.
Horellou, Philippe, Lorraine Flet‐Berliac, Carole Leroy, et al.. (2023). Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children. Brain Communications. 5(2). fcad063–fcad063. 4 indexed citations
5.
Horellou, Philippe, Aliénor de Chalus, Laetitia Giorgi, et al.. (2021). Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children. Frontiers in Immunology. 12. 679770–679770. 11 indexed citations
6.
Maurey, Hélène, Carole Leroy, Philippe Horellou, et al.. (2021). Progressive Leukodystrophy-Like Demyelinating Syndromes with MOG-Antibodies in Children: A Rare Under-Recognized Phenotype. Neuropediatrics. 52(4). 337–340. 6 indexed citations
7.
Serguera, Ché, Lev Stimmer, Claire-Maëlle Fovet, et al.. (2019). Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases. Journal of Neuroinflammation. 16(1). 244–244. 13 indexed citations
8.
Deiva, Kumaran, Hélène Maurey, Caroline Sevin, et al.. (2017). Intra cerebral administration of AAVrh-10 carrying human SGSH and SUMF1 cDNAs in children with MPSIIIA disease: Long term follow-up of a phase I–II trial. European Journal of Paediatric Neurology. 21. e133–e133. 1 indexed citations
9.
Krastinova, Evguenia, Camille Lécuroux, Carole Leroy, et al.. (2015). High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression. The Journal of Infectious Diseases. 212(6). 909–913. 27 indexed citations
10.
Lainey, Élodie, Marie Sébert, Sylvain Thépot, et al.. (2012). Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle. 11(21). 4079–4092. 43 indexed citations
11.
Lainey, Élodie, Nicolas Marie, David Enot, et al.. (2012). Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene. 32(37). 4331–4342. 40 indexed citations
12.
Thépot, Sylvain, Élodie Lainey, Thomas Cluzeau, et al.. (2011). Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle. 10(14). 2323–2330. 43 indexed citations
13.
Lainey, Élodie, Marie Sébert, Carole Leroy, et al.. (2011). Potentiation of Apoptosis in MDS/AML by Combination of Azacitidine and the EGFR-Tyrosine Kinase Inhibitor (TKI) erlotinib. Blood. 118(21). 2790–2790. 2 indexed citations
14.
Lainey, Élodie, Marie Sébert, Carole Leroy, et al.. (2011). Erlotinib Antagonizes Efflux Via ABC Transporters and Decreases P-Gp Cell Surface Expression by Inhibiting SRC Kinase and mTOR Pathways in Acute Myeloid Leukemia (AML). Blood. 118(21). 2564–2564. 2 indexed citations
15.
Gonzalez, Virginie, Audrey Combe, Violaine David, et al.. (2009). Host Cell Entry by Apicomplexa Parasites Requires Actin Polymerization in the Host Cell. Cell Host & Microbe. 5(3). 259–272. 107 indexed citations
16.
Coulombel, Laure, Mario Rosemblatt, Marie‐Hélène Gaugler, Carole Leroy, & William Vainchenker. (1992). Cell-cell matrix and cell-cell interactions during hematopoietic differentiation.. PubMed. 9(1). 19–22. 33 indexed citations
17.
Legros, F., et al.. (1989). An Automated Micromethod for Detection of Lytic Antimycobacterial Antibodies by Immune Lysis of Liposomes Sensitized to Tuberculin. Journal of Immunoassay. 10(4). 359–372. 3 indexed citations
18.
Leroy, Carole, et al.. (1970). [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].. PubMed. 18(21). 969–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norbert Blödorn‐Schlicht Breakdown of academic impact, for papers by Hanoch Goldshmidt Breakdown of academic impact, for papers by Paula Embury Breakdown of academic impact, for papers by J.M.R. Saint-Remy Breakdown of academic impact, for papers by Anne Müller Breakdown of academic impact, for papers by Alessandra G. Commodaro Breakdown of academic impact, for papers by Jenny L. Hardison Breakdown of academic impact, for papers by Renee C. Duncan Breakdown of academic impact, for papers by Troels R. Kjær Breakdown of academic impact, for papers by Nadine Cogné
Rankless by CCL
2026